Transient tachypnoea of newborn. Transient tachypnea of newborn
Conditions
Interventions
Intervention 1: Intervention group 1: In this group, infants receive inhaled salbutamol at a dose of 1.25 mg/kg through a nebulizer for 10 minutes. Intervention 2: Intervention group 2: In this group
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Days to 28 Days
Inclusion criteria
Inclusion criteria: Consent of the infant's parents to participate in the study Minimum gestational age of 35 weeks Diagnosis of TTN is based on the criteria of respiratory distress less than 6 hours after birth (respiration rate more than 60 breaths per minute, grunting, nasal flaring or retraction, cyanosis) and known findings on X-ray (fluid in minor fissures, hyperventilation , prominent central vascular markings, flattening of the diaphragm, increased anterior-posterior diameter, bilateral perihilar congestion). Weight more than 2 kg
Exclusion criteria
Exclusion criteria: Meconium aspiration Other known causes of tachypnea in infants such as (RDS, PPHN, pneumonia, meconium aspiration, premature sepsis of infants, polycythemia, hypocalcemia, hypoglycemia) Abnormal auscultation (Murmur) during cardiac examination Tachycardia (number of heart rate more than 180 per minute) or arrhythmia Asphyxia Incidence of drug drug reactions(tremor, hypoglycemia, hypokalemia, increase in blood pressure, tachycardia and arrhythmia)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tachypnea duration. Timepoint: Before the intervention, 30 minutes, 60 minutes and 4 hours after the intervention. Method of measurement: using a watch. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarhad Abolhasan Choobdar
Iran University of Medical Sciences
Outcome results
None listed